Skip to content

Pathological biomarker search for the radiotherapy convalescence prediction factor of the esophageal cancer by the highly sensitive fluorescence immunostaining

Pathological biomarker search for the radiotherapy convalescence prediction factor of the esophageal cancer by the highly sensitive fluorescence immunostaining - Pathological biomarker search for the radiotherapy convalescence prediction factor of the esophageal cancer by the highly sensitive fluorescence immunostaining

Status
Unknown
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000025542
Enrollment
90
Registered
2017-01-05
Start date
2017-01-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

None listed

Sponsors

Tohoku University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Squamous cell carcinoma, adenosquamous cell carcinoma or basaloid carcinoma 2) Resectable disease 3) Clinical stage I, II or III excluding T4b disease (UICC tumor, node, metastasis system TNM classification) 4) Age 20 to 85 years 5) Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 6) No previous surgery for esophageal cancers 7) No previous chemo- or radiotherapy for any malignancies 8) Sufficient organ function 9) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Other primary cancer 2) Psychiatric disease 3) Serious complications 4) Cardiovascular disease or heart failure occur within 3 months 5) Cerebrovascular disease occur within 3 months 6) Active infection 7) With cardiac pacemaker or defibrillator 8) Positive for hepatitis B virus antigen 9) Pregnancy 10) Others who are inadequate to entry this study

Design outcomes

Primary

MeasureTime frame
Relation between various cancer-related factors and progress-free survival period

Countries

Japan

Contacts

Public ContactTakashi Kamei

Tohoku University Department of Surgery

tkamei@med.tohoku.ac.jp022-717-7214

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026